Bloomberg Law
Nov. 15, 2022, 4:08 PMUpdated: Nov. 15, 2022, 4:36 PM

Over-the-Counter Sales Mulled for Opioid Reversal Drug Naloxone (1)

Jeannie Baumann
Jeannie Baumann

Emergent BioSolutions and other makers of naloxone could sell their opioid reversal medication over the counter, under a potential change from the FDA as it works to curb the drug overdose epidemic.

The Food and Drug Administration announcedTuesday it’s conducting a preliminary assessment about whether naloxone is safe and effective enough to be available without a prescription.

The drug, which is also marketed under the brand name Narcan, can rapidly counteract an opioid overdose, potentially lowering death rates from 27 to 46 percent in communities that implemented overdose education and naloxone distribution, according to the National Institute on Drug ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.